A Nanopore Sequencing-based Pharmacogenomic Panel to Personalize Tuberculosis Drug Dosing

Author:

Verma Renu123ORCID,da Silva Kesia Esther1,Rockwood Neesha456,Wasmann Roeland E.7ORCID,Yende Nombuso8,Song Taeksun8ORCID,Kim Eugene1ORCID,Denti Paolo7ORCID,Wilkinson Robert J.459ORCID,Andrews Jason R.1ORCID

Affiliation:

1. Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, California;

2. Manipal Academy of Higher Education, Manipal, India;

3. Institute of Bioinformatics, International Tech Park, Bangalore, India;

4. Wellcome Center for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine and Department Medicine,

5. Department of Infectious Diseases, Imperial College, London, United Kingdom;

6. Department of Medical Microbiology and Immunology, Faculty of Medicine, University of Colombo, Colombo, Sri Lanka; and

7. Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa;

8. Department of Pathology and Institute of Infectious Disease and Molecular Medicine, and

9. Francis Crick Institute, London, United Kingdom

Funder

NIH

UK Research and Innovation – Medical Research Council

Wellcome

Cancer Research UK

Publisher

American Thoracic Society

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3